# | Challenge | AGHD | Acromegaly | PGD | TDF Domains* |
---|---|---|---|---|---|
1 | Challenges communicating with patients, especially in overcoming patients’ barriers and resistances | X | X | X | 1, 2, 4, 5, 6 |
2 | Challenges with the treatment decision-tree | X | X | — | 1, 2, 4, 9, 10 |
3 | Challenges associated with the transition from childhood to teen years, to adulthood | — | — | X | 1, 2, 3, 4, 6, 11 |
4 | Insurance companies processes interfere with clinical decisions | X | X | X | 11 |
5 | Use of appropriate materials to support patient education | X | X | X | 1, 11 |
6 | Referrals between general pediatricians and pediatric endocrinologists (timeliness, appropriate pre-testing) | — | — | X | 1, 4, 6 |
7 | Perceptions of GH therapy | X | — | — | 6 |
8 | Lack of clarity in roles and responsibilities | X | X | X | 3 |
9 | Application of diagnostic tests | X | — | X | 2, 4 |
10 | Lack of screening by primary care | — | X | — | 6 |
11 | Identifying tests needed for at risk co-morbidities | — | — | X | 2, 6 |
12 | Presenting Treatment as optional | X | — | — | 6 |
13 | Inconsistencies between labs (system) | X | X | X | 11 |